STEMPOINT CAPITAL LP
76 holdingsFiling period: 2026-03-31Current AUM: $605.9Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | SRRK | SCHOLAR ROCK HLDG CORP | 1.14M | $51.5M | $49.5M | 8.18% | -28,397 | 2026-03-31 |
| 2 | ABVX | ABIVAX SA | 313.8K | $34.9M | $39.2M | 6.47% | -77,992 | 2026-03-31 |
| 3 | SNDX | SYNDAX PHARMACEUTICALS INC | 1.37M | $28.5M | $23.2M | 3.83% | +26.4K | 2026-03-31 |
| 4 | RVMD | REVOLUTION MEDICINES INC | 381.6K | $27.9M | $53.8M | 8.88% | +319.6K | 2026-03-31 |
| 5 | IMVT | IMMUNOVANT INC | 846.5K | $18.8M | $29.2M | 4.82% | +201.5K | 2026-03-31 |
| 6 | PRAX | PRAXIS PRECISION MEDICINES I | 56.3K | $18.1M | $17.3M | 2.86% | +35.2K | 2026-03-31 |
| 7 | MBX | MBX BIOSCIENCES INC | 499.5K | $14.9M | $32.9M | 5.43% | +420.9K | 2026-03-31 |
| 8 | MLYS | MINERALYS THERAPEUTICS INC | 533.4K | $14.4M | $13.6M | 2.25% | +243.3K | 2026-03-31 |
| 9 | ELVN | ENLIVEN THERAPEUTICS INC | 363.4K | $14.2M | $19.9M | 3.29% | -- | 2026-03-31 |
| 10 | CGON | CG ONCOLOGY INC | 205.6K | $13.9M | $14.6M | 2.42% | -- | 2026-03-31 |
| 11 | — | BIOHAVEN LTD | 1.59M | $13.5M | $13.5M | 2.23% | -- | 2026-03-31 |
| 12 | — | ROIVANT SCIENCES LTD | 385.8K | $10.7M | $10.7M | 1.76% | -580,898 | 2026-03-31 |
| 13 | EYPT | EYEPOINT INC | 810.8K | $10.4M | $9.9M | 1.64% | +456.9K | 2026-03-31 |
| 14 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | 413.8K | $9.7M | $11.1M | 1.83% | +189.1K | 2026-03-31 |
| 15 | GPCR | STRUCTURE THERAPEUTICS INC | 200.3K | $9.7M | $9.6M | 1.59% | -150,806 | 2026-03-31 |
| 16 | AMLX | AMYLYX PHARMACEUTICALS INC | 669.7K | $9.3M | $13.6M | 2.24% | +104.5K | 2026-03-31 |
| 17 | DYN | DYNE THERAPEUTICS INC | 506.1K | $9.2M | $12.7M | 2.10% | -329,125 | 2026-03-31 |
| 18 | EWTX | EDGEWISE THERAPEUTICS INC | 290.9K | $9.2M | $11.2M | 1.84% | -70,012 | 2026-03-31 |
| 19 | CYTK | CYTOKINETICS INC | 129.6K | $8.5M | $10.0M | 1.65% | -17,401 | 2026-03-31 |
| 20 | SYRE | SPYRE THERAPEUTICS INC | 167.6K | $8.5M | $16.5M | 2.72% | +135.2K | 2026-03-31 |
| 21 | DNLI | DENALI THERAPEUTICS INC | 426.6K | $8.2M | $9.8M | 1.62% | +7.5K | 2026-03-31 |
| 22 | XENE | XENON PHARMACEUTICALS INC | 140.8K | $8.2M | $8.8M | 1.46% | -207,850 | 2026-03-31 |
| 23 | CLDX | CELLDEX THERAPEUTICS INC NEW | 254.3K | $8.1M | $9.7M | 1.60% | -- | 2026-03-31 |
| 24 | TYRA | TYRA BIOSCIENCES INC | 293.2K | $7.7M | $6.4M | 1.06% | -- | 2026-03-31 |
| 25 | PTGX | PROTAGONIST THERAPEUTICS INC | 72.6K | $7.6M | $9.9M | 1.64% | +13.1K | 2026-03-31 |
← Scroll →
Page 1 of 4